18:45:53 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



THC Biomed Intl Ltd
Symbol THC
Shares Issued 163,676,056
Close 2023-07-06 C$ 0.04
Market Cap C$ 6,547,042
Recent Sedar Documents

THC Biomed begins shipping prerolls to B.C.

2023-07-06 07:29 ET - News Release

Mr. John Miller reports

THC BIOMED ANNOUNCES THE SHIPMENT OF PRE-ROLLS AND NEW SUMMER GUMMY PRODUCT LINE TO BRITISH COLUMBIA

THC Biomed Intl Ltd. has begun shipping its premium prerolls to the province of British Columbia.

In addition, THC Biomed is thrilled to share that its recently introduced summer gummy product line has been approved for distribution by the province. This marks a significant milestone for the company as it continues to expand its product offerings and solidify its presence in the dynamic cannabis market.

"We are thrilled to extend our portfolio of products to consumers in British Columbia," says John Miller, chief executive officer. "With the shipment of our prerolls and the approval of our exciting new summer gummy line, we aim to meet the diverse needs of our customers while delivering high-quality, innovative products that stay true to our core values."

THC Biomed is renowned for its commitment to offering a range of premium cannabis products designed to cater to the unique preferences of medical patients and recreational consumers alike. The company's prerolls, known for their superior quality, and the recently introduced summer gummy line, are prime examples of this continuing commitment.

As THC Biomed continues to broaden its reach across the Canadian market, the company remains focused on its mission to provide safe, effective and accessible cannabis products to its customers.

For additional information about THC Biomed's product lines or to stay updated on the company's latest developments, visit its website.

About THC Biomed Intl Ltd.

THC Biomed Intl is a Cannabis Act licensed producer of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The company is on the leading edge of scientific research and the development of products and services related in the medical cannabis industry. Patient safety is not merely a goal but a guiding principle for THC Biomed.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.